Successful Treatment of Refractory Juvenile Dermatomyositis With Adalimumab.
Section of Rheumatology Department of Internal Medicine National Cheng Kung University Hospital Tainan, Taiwan wangcr@mail.ncku.edu.tw.
Chrong-Reen
CR
Wang
D000068879:Adalimumab / Q000008:administration & dosage*; D000293:Adolescent; D018501:Antirheumatic Agents / Q000008:administration & dosage; D003882:Dermatomyositis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007279:Injections, Subcutaneous; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D053580:Muscle Strength / Q000187:drug effects*; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D000068879:Adalimumab